Results 341 to 350 of about 1,846,702 (390)

Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice. [PDF]

Nat Commun
Ssebyatika G, Dinkelborg K, Ströh LJ, Hinte F, Corneillie L, Hueffner L, Guzman EM, Nankya PL, Plückebaum N, Fehlau L, Garn J, Meyer N, Prallet S, Mehnert AK, Kraft ARM, Verhoye L, Jacobsen C, Steinmann E, Wedemeyer H, Viejo-Borbolla A, Dao Thi VL, Pietschmann T, Lütgehetmann M, Meuleman P, Dandri M, Krey T, Behrendt P.   +26 more
europepmc   +1 more source

FOXM1 Protects Against Myocardial Ischemia‐Reperfusion Injury in Rodent and Porcine Models by Suppressing MKRN1‐Dependent LKB1 Ubiquitination

Advanced Science, EarlyView.
FOXM1 maintains mitochondrial bioenergetic function by inhibiting MKRN1‐mediated ubiquitination of LKB1 in cardiomyocytes. Loss of FOXM1 in cardiomyocytes results in upregulation of MKRN1, which enhances LKB1 ubiquitination and disrupts AMPK signaling and energy metabolism pathways. Conversely, FOXM1 overexpression preserves mitochondrial bioenergetics
Shuai Song, Xiaokai Zhang, Zihang Huang, Zhiqiang Pei, Linqi Zeng, Fengze Cai, Tongyao Wang, Mohan Li, Chenyan Liu, Yining Song, Jiahao Guo, Hao Lu, Xinyu Weng, Li Shen, Xiaochun Zhang, Xingxing Cai, Aijun Sun, Junbo Ge   +17 more
wiley   +1 more source

Truncated VZV gE Induces High-Titer Neutralizing Antibodies in Mice. [PDF]

Vaccines (Basel)
Wu J, Li H, Yuan Y, Wang R, Shi T, Li Z, Cui Q, Fu S, Nie K, Li F, Yin Q, Du J, Wang H, Xu S.   +13 more
europepmc   +1 more source

Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery

Aggregate, EarlyView.
This review highlights recent progress in cell membrane‐coated lipid nanoparticles (CMC‐LNPs), focusing on their design, preparation methods, functional integration, and biomedical applications. It discusses various types of LNPs and coating strategies, characterization techniques, therapeutic functions, and applications.
Moataz B. Zewail, Guangze Yang, Yilong Fan, Yue Hui, Chun‐Xia Zhao, Yun Liu   +5 more
wiley   +1 more source

Facile quantitative diagnostic testing for neutralizing antibodies against Chikungunya virus. [PDF]

BMC Infect Dis
Lin HC, Chang SF, Su CL, Hu HC, Chiao DJ, Hsu YL, Lu HY, Lin CC, Shu PY, Kuo SC.   +9 more
europepmc   +1 more source

Screening of Neutralizing Antibodies against FaeG Protein of Enterotoxigenic Escherichia coli. [PDF]

Vet Sci
Tian Y, Lu S, Zhou S, Li Z, Guan S, Chen H, Song Y.   +6 more
europepmc   +1 more source

Remapping the spatial distribution of neutralizing sites and their immunodominance on the capsid of different topotypes of FMDV serotype O by site-directed competitive ELISA for detection of neutralizing antibodies. [PDF]

Microbiol Spectr
Zhao Q, Li F, Huang S, Xing X, Sun Y, Li P, Bao H, Fu Y, Sun P, Bai X, Yuan H, Ma X, Zhao Z, Zhang J, Wang J, Wang T, Li D, Zhang Q, Qian P, Cao Y, Li K, Li X, Lu Z.   +22 more
europepmc   +1 more source

Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans. [PDF]

Nat Microbiol
Kalimuddin S, Tham CYL, Chan YFZ, Hang SK, Kunasegaran K, Chia A, Chan CYY, Ng DHL, Sim JXY, Tan HC, Syenina A, Ngoh AQ, Hamis NZ, Chew V, Leong YS, Yee JX, Low JG, Chan KR, Ong EZ, Bertoletti A, Ooi EE.   +20 more
europepmc   +1 more source

On the Nature of the Interactions That Govern COV-2 Mutants Escape from Neutralizing Antibodies. [PDF]

Molecules
Sussman F, Villaverde DS.
europepmc   +1 more source

Fc-FcγR interactions during infections: From neutralizing antibodies to antibody-dependent enhancement. [PDF]

Immunol Rev
Edgar JE, Bournazos S.
europepmc   +1 more source